Company profile
Website
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
822603419
SEC advisor number
801-113810
FINRA CRD number
289887
AUM ?
$44.05 mm
(as of 31 Mar 20)
Accounts
2
(as of 31 Mar 20)
Employees
3
(3 investment advisory or research)
Address
Caligan Partners
520 MADISON AVENUE
NEW YORK
NY 10022
520 MADISON AVENUE
NEW YORK
NY 10022
Phone
718-570-6018
Latest filings (excl ownership)
PRRN14A
Revised preliminary proxy statement filed by non-management
6 Apr 23
CORRESP
Correspondence with SEC
6 Apr 23
PREC14A
Preliminary proxy with contested solicitation
30 Mar 23
DFAN14A
Additional proxy materials by non-management
21 Feb 23
DFRN14A
Revised proxy by non-management
26 Sep 19
DFAN14A
Additional proxy materials by non-management
26 Sep 19
DFAN14A
Additional proxy materials by non-management
16 Sep 19
DFAN14A
Additional proxy materials by non-management
16 Sep 19
DEFC14A
Proxy in contested solicitation
16 Sep 19
DFAN14A
Additional proxy materials by non-management
4 Sep 19
Latest ownership filings
SC 13D/A
Anika Therapeutics, Inc.
6 Mar 24
4
DAVID EDWARD JOHNSON
22 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
SC 13D/A
STANDARD BIOTOOLS INC.
8 Jan 24
4
DAVID EDWARD JOHNSON
14 Dec 23
SC 13D/A
Liquidia Corp
14 Dec 23
4
DAVID EDWARD JOHNSON
29 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Nov 23
4
DAVID EDWARD JOHNSON
15 Sep 23
SC 13D/A
Anika Therapeutics, Inc.
11 Sep 23
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Feb 24 | Johnson David Edward | Common Stock | Buy | Acquire P | Yes | No | 20.6986 | 190,000 | 3.93 mm | 1,100,730 |
14 Dec 23 | Caligan Partners | Common Stock, $0.001 par value per share ("Common Stock") | Buy | Acquire P | Yes | No | 7.16 | 1,117,318 | 8.00 mm | 11,280,945 |
27 Nov 23 | Johnson David Edward | Common Stock | Buy | Acquire P | Yes | No | 21.61 | 120,409 | 2.60 mm | 910,730 |
27 Nov 23 | Johnson David Edward | Common Stock | Sell | Dispose S | Yes | No | 21.61 | 120,409 | 2.60 mm | 790,321 |
14 Sep 23 | Caligan Partners | Common Stock | Buy | Acquire P | Yes | No | 3.39 | 579,000 | 1.96 mm | 16,835,154 |
14 Sep 23 | Caligan Partners | Common Stock, par value 0.01 per share (Common Stock) | Sell | Dispose S | Yes | No | 3.39 | 579,000 | 1.96 mm | 16,256,154 |
14 Sep 23 | Caligan Partners | Notional Derivative Agreements (obligation to buy) Common Stock | Other | Acquire J | Yes | No | 0 | 1 | 0.00 | 490,000 |
15 Aug 23 | Caligan Partners | Common Stock | Conversion | Acquire C | Yes | No | 1.7 | 13,431,616 | 22.83 mm | 16,835,154 |
15 Aug 23 | Caligan Partners | Common Stock, par value $0.01 per share ("Common Stock") | Conversion | Acquire C | Yes | No | 2.1 | 2,924,761 | 6.14 mm | 3,403,538 |
15 Aug 23 | Caligan Partners | Series B Preferred Common Stock | Conversion | Dispose C | Yes | No | 1.7 | 13,431,616 | 22.83 mm | 0 |